|
PXL/HO/Cir-089/2024-25 Date: 13.02.2025
Hyderabad
Subject: Report on "Healing the World: A Roadmap for Making India a Global Pharma Exports Hub"
Dear Members,
We are pleased to present the report “Healing the World: A Roadmap for Making India a Global Pharma Exports Hub, developed by Bain & Company, in collaboration with Pharmexcil, IPA, and IDMA. This strategic report outlines the path for India to become a global pharmaceutical powerhouse by 2030 and beyond, aligning with India’s broader economic goals for 2047.
Click Here for REPORT
Key Highlights:
-
India’s Pharma Industry in Growth: India is a leading global supplier of generics, contributing 20% of global generics demand. The industry plays a vital role in India’s economy, and with an ambitious target to become a $30-35 trillion economy by 2047, pharma will be a key driver of this growth.
-
Volume to Value Shift: While India dominates in volume, there’s a critical need to shift towards high-value products like biosimilars, innovative therapies, and specialty generics, enhancing the country's global pharma standing.
-
Key Trends Shaping India’s Pharma Future
-
Supply Chain Resilience
-
R&D and Quality Enhancement
-
Rise of CDMOs and CROs
-
Digital Transformation and Sustainability
-
Projected Growth: India’s pharmaceutical exports are set to grow 10-15 times, reaching $350 billion by 2047, driven by emerging opportunities in biosimilars, vaccines, and innovative products.
-
The QuRATE Framework: The report introduces the QuRATE framework, which focuses on Quality, Regulation, Access to global markets, Talent, and Entrepreneurial innovation as core pillars to boost exports and leadership.
-
Strategic Focus Areas:Expanding exports of specialty generics, APIs, vaccines, and leveraging the China+1 strategy for CDMO services are crucial to capturing growth opportunities.
-
Collaboration for Success: Close collaboration between the government and private sector is essential for realizing this vision and transitioning from volume-based exports to a value-driven approach.
The Roadmap offers a clear pathway for India to strengthen its position in global pharma exports, contributing significantly to the country’s economic growth. We encourage all members to align strategies with these insights and seize the emerging opportunities.
Regards
Raja Bhanu
Director General
|
